• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON LABORATORIES IRELAND LTD. CLAREON VIVITY EXTENDED VISION UV ABSORBING IOL; EXTENDED DEPTH OF FOCUS INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON LABORATORIES IRELAND LTD. CLAREON VIVITY EXTENDED VISION UV ABSORBING IOL; EXTENDED DEPTH OF FOCUS INTRAOCULAR LENS Back to Search Results
Model Number CCWET0
Medical Device Problem Code Device Contamination with Chemical or Other Material (2944)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/19/2022
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
A sample device was not returned for analysis.Product history records were reviewed and documentation indicated the product met release criteria.Root cause has not been identified.There have been no other complaints reported in the lot number.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
A nurse reported that during an intraocular lens (iol) implant surgery, nurse found that, lens had something on it (unspecified).Additional information has been requested and received stated that there was no patient harm, patient was not hospitalized.The lens was removed and replaced with another lens.
 
Additional Manufacturer Narrative
Iol returned in two pieces (cut in half) in the lens case.A significant amount of solution is dried on both surfaces of the optic and haptics, what appears to be blood is also dried into the solution.Both haptics are bent.The optic is torn/split-cut, scratched/marked with white particulate-rejectable.The root cause for the reported foreign material could not be determined.The product was subject to handling and the reported complaint was highlighted post implantation.Labs results (see attached) suggests the ¿foreign material¿ is dried salts.The foreign material could not be identified through lab analysis.Based on our investigation results, the origin of the observed ¿foreign material¿ cannot be confirmed.Based on the results from the product history record, the products met release criteria.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLAREON VIVITY EXTENDED VISION UV ABSORBING IOL
Common Device Name
EXTENDED DEPTH OF FOCUS INTRAOCULAR LENS
Manufacturer (Section D)
ALCON LABORATORIES IRELAND LTD.
cork business&technology park
model farm road
cork 00000
EI  00000
Manufacturer (Section G)
ALCON LABORATORIES IRELAND LTD.
cork business&technology park
model farm road
cork 00000
EI   00000
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key14401076
Report Number9612169-2022-00224
Device Sequence Number17405770
Product Code POE
UDI-Device Identifier00380652405737
UDI-Public00380652405737
Combination Product (Y/N)N
Initial Reporter StateNE
Initial Reporter CountryUS
PMA/510(K) Number
P190018
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date (Section B) 09/21/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/27/2025
Device Model NumberCCWET0
Device Catalogue NumberCCWET0.180
Device Lot Number25290884
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 04/21/2022
Supplement Date Received by Manufacturer09/01/2022
Initial Report FDA Received Date05/13/2022
Supplement Report FDA Received Date10/06/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured11/03/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
MONARCH CARTRIDGE D.; MONARCH INJECTOR.; PROVISC.
Patient Age72 YR
Patient SexFemale
-
-